Friedman DJ, Pollak MR (2021) APOL1 nephropathy: from genetics to clinical applications. Clin J Am Soc Nephrol févr 16(2):294–303

Article  CAS  Google Scholar 

Vajgel G, Lima SC, Santana DJS, Oliveira CBL, Costa DMN, Hicks PJ et al (2020) Effect of a single apolipoprotein L1 gene nephropathy variant on the risk of advanced lupus nephritis in Brazilians. J Rheumatol 47(8):1209–1217

Article  CAS  PubMed  Google Scholar 

Salvatore SP, Barisoni LMC, Herzenberg AM, Chander PN, Nickeleit V, Seshan SV (2012) Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease. Clin J Am Soc Nephrol juin 7(6):914–925

Article  Google Scholar 

Larsen CP, Beggs ML, Saeed M, Walker PD (2013) Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy. J Am Soc Nephrol mai 24(5):722–725

Article  CAS  Google Scholar 

Blazer A, Dey ID, Nwaukoni J, Reynolds M, Ankrah F, Algasas H et al (2021) Apolipoprotein L1 risk genotypes in Ghanaian patients with systemic lupus erythematosus: a prospective cohort study. Lupus Sci Med janv 8(1):e000460

Article  Google Scholar 

Freedman BI, Langefeld CD, Andringa KK, Croker JA, Williams AH, Garner NE et al (2014) End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol févr 66(2):390–396

Article  CAS  Google Scholar 

Freedman BI, Burke W, Divers J, Eberhard L, Gadegbeku CA, Gbadegesin R et al (2021) Diagnosis, education, and care of patients with APOL1-associated nephropathy: a Delphi consensus and systematic review. J Am Soc Nephrol juill 32(7):1765–1778

Article  CAS  Google Scholar 

Egbuna O, Zimmerman B, Manos G, Fortier A, Chirieac MC, Dakin LA et al (2023) Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants. N Engl J Med 388(11):969–979

Article  CAS  PubMed  Google Scholar